Pharmacological perturbation of intracellular dynamics as a SARS-CoV-2 antiviral strategy
Preprint
Abstract
SARS-CoV-2 (CoV2) is the viral agent responsible for the pandemic of the coronavirus disease 2019 (COVID-19). Vaccines are being deployed all over the world with good efficacy, but there is no approved antiviral treatment to date. This is particularly needed since the emergence of variants and the potential immune escape may prolong pandemic spreading of the infection for much longer than anticipated. Here, we developed a series of small molecules and identified RG10 as a potent antiviral compound against SARS-CoV-2 in cell lines and human airway epithelia (HAE). RG10 localizes to endoplasmic reticulum (ER) membranes, perturbing ER morphology and inducing ER stress. Yet, RG10 does not associate with SARS-CoV-2 replication sites although preventing virus replication. To further investigate the antiviral properties of our compound, we developed fluorescent SARS-CoV-2 viral particles allowing us to track virus arrival to ER membranes. Live cell imaging of replication-competent virus infection revealed that RG10 stalls the intracellular virus-ER dynamics. Finally, we synthesized RG10b, a stable version of RG10, that showed increased potency in vitro and in HAE with a pharmacokinetic half-life greater than 2 h. Together, our work reports on a novel fluorescent virus model and innovative antiviral strategy consisting of the perturbation of ER/virus dynamics, highlighting the promising antiviral properties of RG10 and RG10b.Keywords
This publication has 27 references indexed in Scilit:
- An Infectious cDNA Clone of SARS-CoV-2Cell Host & Microbe, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 2020
- Structure, function and antigenicity of the SARS-CoV-2 spike glycoproteinbioRxiv, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus ReplicationJournal of Virology, 2019
- Opportunistic intruders: how viruses orchestrate ER functions to infect cellsNature Reviews Microbiology, 2016
- Sorting of small infectious virus particles by flow virometry reveals distinct infectivity profilesNature Communications, 2015
- Reverse Genetics of SARS-Related Coronavirus Using Vaccinia Virus-Based RecombinationPLOS ONE, 2012
- Robust hepatitis C virus infectionin vitroProceedings of the National Academy of Sciences, 2005